1. Home
  2. HAE vs JPC Comparison

HAE vs JPC Comparison

Compare HAE & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.16

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Preferred & Income Opportunities Fund

JPC

Nuveen Preferred & Income Opportunities Fund

HOLD

Current Price

$7.79

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAE
JPC
Founded
1971
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
1996
2003

Fundamental Metrics

Financial Performance
Metric
HAE
JPC
Price
$59.16
$7.79
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$84.13
N/A
AVG Volume (30 Days)
758.2K
880.3K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
44.54
N/A
EPS
2.46
N/A
Revenue
$910,373,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.23
N/A
P/E Ratio
$23.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.32
$7.22
52 Week High
$87.32
$8.30

Technical Indicators

Market Signals
Indicator
HAE
JPC
Relative Strength Index (RSI) 55.46 42.93
Support Level $49.26 $7.22
Resistance Level $62.48 $8.25
Average True Range (ATR) 3.21 0.07
MACD 0.38 -0.04
Stochastic Oscillator 85.46 40.11

Price Performance

Historical Comparison
HAE
JPC

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About JPC Nuveen Preferred & Income Opportunities Fund

Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its primary investment objective is to provide high current income, and its secondary investment objective is total return. The fund invests a majority of its assets in preferred securities and other income-producing securities, including hybrid securities such as contingent capital securities, and the rest of its investments are made in other securities, mainly income-oriented securities such as corporate and taxable municipal debt and common equity.

Share on Social Networks: